Debt to Equity Ratio: 5.78
Is the debt to equity ratio high or low?
The debt to equity ratio of 5.78 is 263% above its 5-year average of 1.59, near the high end of its 5-year range (0.26–5.78).
As of Saturday, June 27, 2026. 25.61% above its 12-month average of 4.60.
NRC Debt to Equity Ratio
Reported quarterly debt to equity ratio; no daily interpolation.
NRC Average Debt to Equity Ratio Chart
NRC Current vs Average Debt to Equity Ratio Chart
NRC Debt to Equity Ratio Metrics
DEBT TO EQUITY RATIO
5.78
DEBT TO EQUITY RATIO AVG TTM
4.60
DEBT TO EQUITY RATIO AVG 3Y
2.35
DEBT TO EQUITY RATIO AVG 5Y
0.91
DEBT TO EQUITY RATIO AVG 10Y
0.65
DEBT TO EQUITY RATIO AVG 15Y
0.47
DEBT TO EQUITY RATIO AVG 20Y
0.21
CURRENT VS TTM AVG
+25.61%
CURRENT VS 3Y AVG
+145.87%
CURRENT VS 5Y AVG
+533.12%
CURRENT VS 10Y AVG
+784.26%
CURRENT VS 15Y AVG
+1143.30%
CURRENT VS 20Y AVG
+2634.75%
NRC Competitors' Debt to Equity Ratio
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| National Research Corporation (NRC) | $468.99M | 5.78 | 4.60 | 2.35 | 0.91 |
| Shoulder Innovations, Inc. (SI)vs › | $472.62M | 0.10 | 0.42 | 0.42 | 0.42 |
| 23andMe Holding Co. (ME)vs › | $15.31M | -2.56 | 0.27 | 0.25 | 0.34 |
| Teladoc Health, Inc. (TDOC)vs › | $1.51B | 0.75 | 0.91 | 0.80 | 0.56 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | 1.84 | 1.50 | 1.07 | 0.87 |
| TransMedics Group, Inc. (TMDX)vs › | $2.37B | 0.99 | 1.63 | 1.85 | 1.39 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.57B | 2.07 | 1.04 | 0.53 | 0.36 |
| Oscar Health, Inc. (OSCR)vs › | $7.72B | 0.44 | 0.37 | 0.36 | 0.29 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.13B | 0.21 | 0.21 | 0.18 | 0.13 |
| Universal Health Services, Inc. (UHS)vs › | $9.12B | 0.76 | 0.75 | 0.81 | 0.78 |
Financial Health
Debt/Equity
5.78
Current Ratio
0.55
Debt to Equity Ratio Formula & Definition
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Debt to Equity Ratio FAQ
- What is the debt to equity ratio for National Research Corporation (NRC)?
- The debt to equity ratio for NRC stock is 5.78.
- Is National Research Corporation's debt to equity ratio high or low?
- The debt to equity ratio of 5.78 is 263% above its 5-year average of 1.59, near the high end of its 5-year range (0.26–5.78).
- What is the TTM average debt to equity ratio for National Research Corporation (NRC)?
- The TTM average debt to equity ratio for NRC stock is 4.60.
- What is the 3Y average debt to equity ratio for National Research Corporation (NRC)?
- The 3Y average debt to equity ratio for NRC stock is 2.35.
- What is the 5Y average debt to equity ratio for National Research Corporation (NRC)?
- The 5Y average debt to equity ratio for NRC stock is 0.91.
- What is the 10Y average debt to equity ratio for National Research Corporation (NRC)?
- The 10Y average debt to equity ratio for NRC stock is 0.65.
- What is the 15Y average debt to equity ratio for National Research Corporation (NRC)?
- The 15Y average debt to equity ratio for NRC stock is 0.47.
- What is the 20Y average debt to equity ratio for National Research Corporation (NRC)?
- The 20Y average debt to equity ratio for NRC stock is 0.21.
NRC Debt to Equity Ratio History
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-03-31 | 5.78 |
| 2025-12-31 | 5.65 |
| 2025-09-30 | 5.59 |
| 2025-06-30 | 3.80 |
| 2025-03-31 | 2.20 |
| 2024-12-31 | 2.06 |
| 2024-09-30 | 1.55 |
| 2024-06-30 | 1.05 |
| 2024-03-31 | 1.14 |
| 2023-12-31 | 0.81 |
| 2023-09-30 | 0.41 |
| 2023-06-30 | 0.26 |
| 2023-03-31 | 0.28 |
| 2022-12-31 | 0.32 |
| 2022-09-30 | 0.34 |
| 2022-06-30 | 0.36 |
| 2022-03-31 | 0.31 |
| 2021-12-31 | 0.34 |
| 2021-09-30 | 0.36 |
| 2021-06-30 | 0.41 |
| 2021-03-31 | 0.45 |
| 2020-12-31 | 0.52 |
| 2020-09-30 | 0.61 |
| 2020-06-30 | 0.78 |
| 2020-03-31 | 0.95 |
| 2019-12-31 | 1.11 |
| 2019-09-30 | 1.21 |
| 2019-06-30 | 1.43 |
| 2019-03-31 | 1.70 |
| 2018-12-31 | 0.19 |
| 2018-09-30 | 1.29 |
| 2018-06-30 | 1.48 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.01 |
| 2017-09-30 | 0.02 |
| 2017-06-30 | 0.03 |
| 2017-03-31 | 0.03 |
| 2016-12-31 | 0.03 |
| 2016-09-30 | 0.03 |
| 2016-06-30 | 0.06 |
| 2016-03-31 | 0.07 |
| 2015-12-31 | 0.03 |
| 2015-09-30 | 0.07 |
| 2015-06-30 | 0.08 |
| 2015-03-31 | 0.09 |
| 2014-12-31 | 0.03 |
| 2014-09-30 | 0.03 |
| 2014-06-30 | 0.11 |
| 2014-03-31 | 0.13 |
| 2013-12-31 | 0.03 |
| 2013-09-30 | 0.16 |
| 2013-06-30 | 0.19 |
| 2013-03-31 | 0.20 |
| 2012-12-31 | 0.22 |
| 2012-09-30 | 0.20 |
| 2012-06-30 | 0.03 |
| 2012-03-31 | 0.04 |
| 2011-12-31 | 0.27 |
| 2011-09-30 | 0.04 |
| 2011-06-30 | 0.06 |
| 2011-03-31 | 0.31 |
| 2010-12-31 | 0.33 |
| 2010-09-30 | 0.04 |
| 2010-06-30 | 0.02 |
| 2010-03-31 | 0.02 |
| 2009-12-31 | 0.17 |
| 2009-09-30 | 0.02 |
| 2009-06-30 | 0.02 |
| 2009-03-31 | 0.27 |
| 2008-12-31 | 0.34 |
| 2008-09-30 | 0.01 |
| 2008-06-30 | 0.08 |
| 2008-03-31 | 0.18 |
| 2007-12-31 | 0.07 |
| 2007-09-30 | 0.12 |
| 2007-06-30 | 0.17 |
| 2007-03-31 | 0.22 |
| 2006-12-31 | 0.30 |
| 2006-09-30 | 0.08 |
| 2006-06-30 | 0.36 |
| 2006-03-31 | 0.01 |
| 2005-12-31 | 0.05 |
| 2005-09-30 | 0.14 |
| 2005-06-30 | 0.15 |
| 2005-03-31 | 0.14 |
| 2004-12-31 | 0.14 |
| 2004-09-30 | 0.15 |
| 2004-06-30 | 0.15 |
| 2004-03-31 | 0.15 |
| 2003-12-31 | 0.16 |
| 2003-09-30 | 0.16 |
| 2003-06-30 | 0.17 |
| 2003-03-31 | 0.18 |
| 2002-12-31 | 0.18 |
| 2002-09-30 | 0.20 |
| 2002-06-30 | 0.21 |
Related Metrics
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green